Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2024-03-01 Regulatory Filings
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-03-01 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to the issuance of senior notes, details about the underwriting agreement, and the creation of a direct financial obligation. It also references exhibits such as the underwriting agreement, indenture, and legal opinions. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The document is focused on a capital raising event and related agreements, which aligns with a Capital/Financing Update. The length (9,323 characters) and detailed content confirm it is the report itself, not just an announcement of a report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-02-27 English
Director's Dealing 2024
Director's Dealing
2024-02-27 English
Regulatory Filings 2024
Regulatory Filings
2024-02-26 English
Director's Dealing 2024
Director's Dealing
2024-02-26 English
424B2
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and accompanying prospectus filed pursuant to Rule 424(b)(2) related to a debt securities offering by American Medical Systems Europe B.V., a finance subsidiary of Boston Scientific Corporation. It details the terms of senior notes issuance, use of proceeds, underwriting, and legal matters. The document is a detailed capital markets offering disclosure, not a financial report, earnings release, or management discussion. It is clearly a financing update related to debt issuance and capital raising activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to explicit content about debt offering and financing terms.
2024-02-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.